Delivery Order SPE2DB22D1017-SPE2DB25FG6VV
- Not listed
- This is a $1,358.05 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ADACEL TDAP VIAL 0.5ML. The contract has an ultimate completion date of July 11, 2025 and is not set aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- This is a $3,617.06 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ADACEL TDAP VIAL 0.5ML medical supplies, with a period of performance through July 16, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of ADACEL TDAP VIAL 0.5ML, a pharmaceutical product, with a potential value of $3,710.74 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this...
- This is a $1,742.00 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADACEL TDAP SYRINGE 5S, a medical supply item, with a completion date of July 3, 2025. The award is under a Firm Fixed Price contract type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,842,229 units of the ADACEL TDAP VIAL 0.5ML pharmaceutical product. The $3,831.60 delivery order has a performance period through March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of ADACEL TDAP SYRINGE 0.5ML. The firm-fixed-price contract, valued at $1,340.00, has a completion date of June 13, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ADACEL TDAP VIAL 0.5ML, a vaccine product, with a firm fixed price of $1,248.06 and a period of performance through June 18, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of ADACEL TDAP VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $2,906.34 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 31, 2024, with a completion date of June 3, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADACEL TDAP SYRINGE 0.5ML, with a ceiling value of $1,072.00 and a period of performance through May 20, 2025. The contract is not set aside and was awarded on May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a delivery order with a firm fixed price of $1,086.44 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Adacel TDAP Vial 0.5ML, a vaccine product, with an ultimate completion date of June 25, 2025. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG6VVDelivery Order
This is a $1,453.61 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ADACEL TDAP VIAL 0.5ML, a pharmaceutical product, with a completion date of July 9, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/8/25 |